Industry News
Three patients received a 30-minute test of Coherence Neuro's brain-tumor implant at Royal Melbourne Hospital
Coherence Neuro placed its cancer-targeting brain-computer interface in three patients for 30 minutes during brain tumor resection at Royal Melbourne Hospital, with a permanent-implant glioblastoma trial planned for 2027.